EP 0993449 A1 20000419 - QUINOLINE DERIVATIVES AS PDE IV AND/OR TNF INHIBITORS
Title (en)
QUINOLINE DERIVATIVES AS PDE IV AND/OR TNF INHIBITORS
Title (de)
CHINOLINDERIVATE ALS PDE IV UND/ODER TNF INHIBITOREN
Title (fr)
DERIVES DE QUINOLINE UTILISES EN TANT QU'INHIBITEURS DE LA PDE IV ET/OU DU TNF
Publication
Application
Priority
- GB 9801770 W 19980617
- GB 9712761 A 19970617
Abstract (en)
[origin: WO9857936A1] Compounds of formula (i) wherein R1 represents C1-6 alkoxy (alkyl portion optionally substituted with one or more halogens) or thioalkyl; Q represents an aryl or heteroaryl ring, attached through any appropriate atom and optionally substituted at any position(s) with one or more substituents R5. The compounds can be used to treat disease states, for example disease states associated with proteins that mediate cellular activity, for example by inhibiting tumour necrosis factor and/or by inhibiting phosphodiesterase IV.
IPC 1-7
IPC 8 full level
A61K 31/47 (2006.01); A61P 1/00 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); A61P 11/00 (2006.01); A61P 11/02 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01); A61P 25/00 (2006.01); A61P 25/16 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/18 (2006.01); A61P 35/02 (2006.01); A61P 37/02 (2006.01); A61P 37/04 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 215/26 (2006.01)
CPC (source: EP)
A61K 31/47 (2013.01); A61P 1/00 (2017.12); A61P 3/10 (2017.12); A61P 9/00 (2017.12); A61P 11/00 (2017.12); A61P 11/02 (2017.12); A61P 11/06 (2017.12); A61P 13/12 (2017.12); A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 25/00 (2017.12); A61P 25/16 (2017.12); A61P 25/24 (2017.12); A61P 25/28 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/18 (2017.12); A61P 35/02 (2017.12); A61P 37/02 (2017.12); A61P 37/04 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07D 215/26 (2013.01); Y02A 50/30 (2017.12)
Citation (search report)
See references of WO 9857936A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9857936 A1 19981223; AU 735573 B2 20010712; AU 8222898 A 19990104; CA 2289100 A1 19981223; CN 1260784 A 20000719; EP 0993449 A1 20000419; GB 9712761 D0 19970820; JP 2002504925 A 20020212; ZA 985253 B 19990617
DOCDB simple family (application)
GB 9801770 W 19980617; AU 8222898 A 19980617; CA 2289100 A 19980617; CN 98806235 A 19980617; EP 98932276 A 19980617; GB 9712761 A 19970617; JP 50397799 A 19980617; ZA 985253 A 19980617